Myeloma: OBI Rivals IV Isatuximab, Ups Patient Comfort ...Middle East

IRAKLIA, the first phase 3 multiple myeloma study to use an on-body injector, finds the same efficacy and pharmacokinetics in isatuximab, with many fewer infusion reactions. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Myeloma: OBI Rivals IV Isatuximab, Ups Patient Comfort )

Also on site :

• Term Sheet Next: How Facebook’s former chief revenue officer is coaching the next generation of startup founders
• At least 7 dead after wave of explosions hit southwest Colombia, authorities say
• Popular Dunkin’ Menu Item Gets a ‘Glow-Up’ in Limited-Edition Release